Applicant, as named in the Orange Book
Chattem Sanofi
Next listed expiry: Xyzal Allergy 24hr on 16 Oct 2027. 2 products with live protection, 7 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Xyzal Allergy 24hr NDA 209090 levocetirizine dihydrochloride | 16 Oct 2027 patent |
| Children's Allegra Allergy NDA 201373 fexofenadine hydrochloride | 2 Aug 2030 patent |
Recent events
- Nasacort Allergy 24 Hour · Generic approved · ANDA 220110, Aurobindo Pharma LtdApproved 11 Aug 2026Detected 25 Oct 2026
- Allegra-D 24 Hour Allergy And Congestion · Generic approved · ANDA 216792, L Perrigo CoApproved 7 Oct 2025Detected 25 Oct 2026
- Children's Allegra Allergy · Generic approved · ANDA 220413, Dr ReddysApproved 30 Jul 2026Detected 25 Oct 2026
- Xyzal Allergy 24hr · Enters 12-month window basis: patentListed date 16 Oct 2027Detected 24 Oct 2026
Products without listed protection (7)
| Drug | Earliest generic entry |
|---|---|
| Allegra Allergy NDA 020872 · 2 strengths fexofenadine hydrochloride | open now no listed protection |
| Allegra Hives NDA 020872 fexofenadine hydrochloride | open now no listed protection |
| Allegra-D 12 Hour Allergy And Congestion NDA 020786 fexofenadine hydrochloride; pseudoephedrine hydrochloride | open now no listed protection |
| Allegra-D 24 Hour Allergy And Congestion NDA 021704 fexofenadine hydrochloride; pseudoephedrine hydrochloride | open now no listed protection |
| Nasacort Allergy 24 Hour NDA 020468 triamcinolone acetonide | open now no listed protection |
| Nicoderm Cq NDA 020165 · 3 strengths nicotine | open now no listed protection |
| Xyzal Allergy 24hr NDA 209089 levocetirizine dihydrochloride | open now no listed protection |